Ondine Biomedical Inc (AIM:OBI), late on Friday, announced it had extended the deadline for its bookbuild process until midday today (Monday 4 December).
The process allows existing shareholders to participate in the placing announced last week.
Ondine said the process had seen indications of strong investor demand.
A further announcement will follow in due course.